My Quote Request
No products added yet
6505-01-106-1827
20 Products
NDC00555-0252-04
DIPYRIDAMOLE TABLETS,USP
NSN, MFG P/N
6505011061827
NSN
6505-01-106-1827
NDC00555-0252-04
DIPYRIDAMOLE TABLETS,USP
NSN, MFG P/N
6505011061827
NSN
6505-01-106-1827
MFG
BARR PHARMACEUTICALS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DIPYRIDAMOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPYRIDAMOLE TABLETS USP 25MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: BOEHRINGER INGELHEIM LABORATORIES
Related Searches:
NDC00641-2450-45
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011054093
NSN
6505-01-105-4093
NDC00641-2450-45
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011054093
NSN
6505-01-105-4093
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1000.000 UNITS HEPARIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR SUBCUTANEOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC39769-0019-30
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011054093
NSN
6505-01-105-4093
NDC39769-0019-30
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011054093
NSN
6505-01-105-4093
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1000.000 UNITS HEPARIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR SUBCUTANEOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
INTROPIN INJECTION
DOPAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011054094
NSN
6505-01-105-4094
INTROPIN INJECTION
DOPAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011054094
NSN
6505-01-105-4094
MFG
DU PONT CRITICAL CARE INC SUB OF E I DU PONT DE NEMOURS AND CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS DOPAMINE HYDROCHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,DUPONT CRITICAL CARE
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: NONPYROGENIC
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
NDC00094-0046-06
DOPAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011054094
NSN
6505-01-105-4094
NDC00094-0046-06
DOPAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011054094
NSN
6505-01-105-4094
MFG
DU PONT CRITICAL CARE INC SUB OF E I DU PONT DE NEMOURS AND CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS DOPAMINE HYDROCHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,DUPONT CRITICAL CARE
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: NONPYROGENIC
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
NDC00186-0210-03
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011054179
NSN
6505-01-105-4179
NDC00186-0210-03
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011054179
NSN
6505-01-105-4179
MFG
ASTRA PHARMACEUTICALS LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIDOCAINE HYDROCHLORIDE INJECTION USP 1% 2ML 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00641-0140-26
MEPERIDINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011054995
NSN
6505-01-105-4995
NDC00641-0140-26
MEPERIDINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011054995
NSN
6505-01-105-4995
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS MEPERIDINE HYDROCHLORIDE PER MILLILITER
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE II
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEPERIDINE HYDROCHLORIDE INJECTION USP VIAL 10S
III PROTECTIVE STORAGE FEATURE: VAULT STORAGE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ELKINS-SINN INC
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 10 VIAL
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: CARTON
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
ARM-A-MED
ISOETHARINE INHALATION SOLUTION,USP
NSN, MFG P/N
6505011054997
NSN
6505-01-105-4997
ARM-A-MED
ISOETHARINE INHALATION SOLUTION,USP
NSN, MFG P/N
6505011054997
NSN
6505-01-105-4997
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 PERCENTAGE, W/V ISOETHARINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00053-4112-01
ISOETHARINE INHALATION SOLUTION,USP
NSN, MFG P/N
6505011054997
NSN
6505-01-105-4997
NDC00053-4112-01
ISOETHARINE INHALATION SOLUTION,USP
NSN, MFG P/N
6505011054997
NSN
6505-01-105-4997
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 PERCENTAGE, W/V ISOETHARINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00054-8430-25
ISOETHARINE INHALATION SOLUTION,USP
NSN, MFG P/N
6505011054997
NSN
6505-01-105-4997
NDC00054-8430-25
ISOETHARINE INHALATION SOLUTION,USP
NSN, MFG P/N
6505011054997
NSN
6505-01-105-4997
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 PERCENTAGE, W/V ISOETHARINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
31000
BENZOCAINE TOPICAL AEROSOL,USP
NSN, MFG P/N
6505011057483
NSN
6505-01-105-7483
MFG
SYNTEX LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, V/V BENZOCAINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BENZOCAINE TOPICAL AEROSOL USP 20% 2FL OZ OR 60ML CONTAINER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 FLUID OUNCES OR 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: CONTAINS A SUITABLE FLAVORING AGENT
Related Searches:
HURRICAINE SPRAY
BENZOCAINE TOPICAL AEROSOL,USP
NSN, MFG P/N
6505011057483
NSN
6505-01-105-7483
HURRICAINE SPRAY
BENZOCAINE TOPICAL AEROSOL,USP
NSN, MFG P/N
6505011057483
NSN
6505-01-105-7483
MFG
BEUTLICH L P
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, V/V BENZOCAINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BENZOCAINE TOPICAL AEROSOL USP 20% 2FL OZ OR 60ML CONTAINER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 FLUID OUNCES OR 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: CONTAINS A SUITABLE FLAVORING AGENT
Related Searches:
NDC00283-0679-02
BENZOCAINE TOPICAL AEROSOL,USP
NSN, MFG P/N
6505011057483
NSN
6505-01-105-7483
NDC00283-0679-02
BENZOCAINE TOPICAL AEROSOL,USP
NSN, MFG P/N
6505011057483
NSN
6505-01-105-7483
MFG
BEUTLICH L P
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, V/V BENZOCAINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BENZOCAINE TOPICAL AEROSOL USP 20% 2FL OZ OR 60ML CONTAINER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 FLUID OUNCES OR 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: CONTAINS A SUITABLE FLAVORING AGENT
Related Searches:
LASIX UNIT OF USE
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057484
NSN
6505-01-105-7484
LASIX UNIT OF USE
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057484
NSN
6505-01-105-7484
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00005-3709-32
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057484
NSN
6505-01-105-7484
NDC00005-3709-32
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057484
NSN
6505-01-105-7484
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00039-0060-06
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057484
NSN
6505-01-105-7484
NDC00039-0060-06
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057484
NSN
6505-01-105-7484
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LASIX UNIT OF USE
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057485
NSN
6505-01-105-7485
LASIX UNIT OF USE
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057485
NSN
6505-01-105-7485
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD RESISTANT CLOSURE
Related Searches:
NDC00005-3709-38
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057485
NSN
6505-01-105-7485
NDC00005-3709-38
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057485
NSN
6505-01-105-7485
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD RESISTANT CLOSURE
Related Searches:
NDC00039-0060-03
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057485
NSN
6505-01-105-7485
NDC00039-0060-03
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505011057485
NSN
6505-01-105-7485
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WITH CHILD RESISTANT CLOSURE
Related Searches:
NDC00005-3743-31
DIPYRIDAMOLE TABLETS,USP
NSN, MFG P/N
6505011061827
NSN
6505-01-106-1827
NDC00005-3743-31
DIPYRIDAMOLE TABLETS,USP
NSN, MFG P/N
6505011061827
NSN
6505-01-106-1827
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DIPYRIDAMOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPYRIDAMOLE TABLETS USP 25MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: BOEHRINGER INGELHEIM LABORATORIES
